NewsRx

Search our medical news database

Influenza Vaccine

Enzyme May Identify Flu Vaccine Failures

Published in Vaccine Weekly, November 1st, 1999

by Daniel J. DeNoon, Senior Editor -- Elderly people who get the flu despite vaccination have low levels of cytotoxic lymphocyte (CTL) activity.

Some of these individuals developed influenza even though they had normally protective levels of antibodies specific for the infecting flu bug strain.

Janet E. McElhaney of Eastern Virginia Medical School, Norfolk, Virginia, and colleagues measured granzyme B responses to influenza vaccination in 100 frail, elderly patients. Granzyme B is the key enzyme involved in CTL-mediated cell killing, a major antiviral immune response.

"Granzyme B may be a cellular marker of vaccine efficacy in...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook